Key facts
- Impilo (Enterprise Systems (Healthcare))’s last known valuation is $42.0M.
- It has raised $18.4M; the latest was Early Stage VC ($11.5M) in Jul 2024.
- Notable investors include TA Ventures, 2048 Ventures, One Way Ventures, Construct Capital, GC1 Ventures — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Impilo (Enterprise Systems (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Impilo (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Impilo (Enterprise Systems (Healthcare))
Developer of digital health operating systems intended to empower healthcare providers to offer top-tier care from the comfort of patients' homes. The company's platform simplifies virtual care operations, educates patients, and empowers providers to connect to care from anywhere. enabling hospitals and healthcare organizations to manage patients' digital health through remote patient monitoring.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Founded
- 2020
- Employees
- 47
- Website
- impilo.health/
- Ownership
- Privately Held (backing)
Impilo (Enterprise Systems (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Impilo (Enterprise Systems (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Impilo (Enterprise Systems (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.